News

Mesoblast Granted U.S. Patent #11,312,941 Stem Cell Composition

View Patent here

byCharles Gross

April 26, 2022

1 minute read

View Patent here

News

ReShape Lifesciences Highlights Launch Of Multi-Platform Consumer Ad Campaign To Market Its Next-Gen Lap Band Program

By Benzinga Newsdesk

October 12, 8:16 AM

The Company’s first and largest mainstream mass-market advertising campaign Featured on major television channels and consumer print publications SAN CLEMENTE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) --

RSLS

London Police Arrested 17-year-old HACKER Suspected of GTA 6 And Uber Leak

By Azhar Khan

September 23, 4:35 PM

A 17-year-old teen is arrested today and a journalist suggests that the teen is suspected for the GTA 6 leak which happened last week along with the Uber leak that happened this month with the connection of hacking group Lapsus$.

TTWO

Evoke Pharma Offers Commercialization Update For GIMOTI: Received Outcomes From Added Research Study

By Benzinga Newsdesk

February 17, 9:39 AM

New Research Study Demonstrates Increased Acceptance Among Healthcare Providers Patient Testimonial Videos Detail Benefits Included and Available on GimotiRx.com Expanded Coverage with recent New York Medicaid

EVOK

FDA
News

Landos Biopharma Announces FDA Clearance Of IND For LABP-104 For Treatment Of Rheumatoid Arthritis

By Benzinga Newsdesk

November 2, 8:29 AM

Landos Biopharma, Inc. (NASDAQ:LABP), a late clinical-stage biopharmaceutical company utilizing its LANCE® Advanced A.I. platform to discover and develop novel therapeutics for patients with autoimmune diseases,

LABP

Mesoblast Granted U.S. Patent #11,312,941 Stem Cell Composition

Related Posts

ReShape Lifesciences Highlights Launch Of Multi-Platform Consumer Ad Campaign To Market Its Next-Gen Lap Band Program

London Police Arrested 17-year-old HACKER Suspected of GTA 6 And Uber Leak

Evoke Pharma Offers Commercialization Update For GIMOTI: Received Outcomes From Added Research Study

Landos Biopharma Announces FDA Clearance Of IND For LABP-104 For Treatment Of Rheumatoid Arthritis